Noticias de ABT_US

Noticias del mercado

Últimas noticias sobre ABT_US — 275 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ABT_US ✕ 275 resultados
22/04/2026 ABT_US — MarketBeat ES ← EN
Moran Wealth Management LLC vende 73.546 acciones de Abbott Laboratories $ABT

Moran Wealth Management LLC Sells 73,546 Shares of Abbott Laboratories $ABT

22/04/2026 ABT_US — Seeking Alpha
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
22/04/2026 ABT_US — Yahoo Finance
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
22/04/2026 ABT_US — 24/7 Wall St.
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More
22/04/2026 ABT_US — Yahoo Finance
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More
21/04/2026 ABT_US — Investing.com ES ← EN
Las acciones de Abbott Laboratories alcanzan el mínimo de 52 semanas a 93,91 USD

Abbott Laboratories stock hits 52-week low at 93.91 USD

21/04/2026 ABT_US — 24/7 Wall St. ES ← EN
Wall Street se niega a parpadear: 2 acciones de atención médica en mínimos de 52 semanas que los analistas aún adoran

Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love

21/04/2026 ABT_US — The Globe and Mail ES ← EN
La UBS mantiene su calificación de compra para Abbott Laboratories (ABT)

UBS Sticks to Their Buy Rating for Abbott Laboratories (ABT)

21/04/2026 ABT_US — MarketBeat ES ← EN
Ticino Wealth compra acciones de 11.005 laboratorios Abbott $ABT

Ticino Wealth Buys Shares of 11,005 Abbott Laboratories $ABT

21/04/2026 ABT_US — MarketBeat ES ← EN
El precio objetivo de Abbott Laboratories (NYSE:ABT) se redujo a 135,00 dólares en UBS Group

Abbott Laboratories (NYSE:ABT) Price Target Lowered to $135.00 at UBS Group

21/04/2026 ABT_US — MarketBeat ES ← EN
Leerink Partners reduce el precio objetivo de Abbott Laboratories (NYSE:ABT) a 106,00 dólares

Leerink Partners Lowers Abbott Laboratories (NYSE:ABT) Price Target to $106.00

21/04/2026 ABT_US — MarketBeat ES ← EN
Argus ha reducido las expectativas sobre el precio de las acciones de Abbott Laboratories (NYSE:ABT)

Argus Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price

21/04/2026 ABT_US — Yahoo Finance ES ← EN
¿El mercado de opciones predice un aumento en las acciones de Abbott Laboratories?
21/04/2026 ABT_US — MarketScreener ES ← EN
Leerink Partners ajusta el PT de Abbott Laboratories a $106 desde $119, mantiene la calificación de desempeño del mercado

Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating

21/04/2026 ABT_US — MarketScreener ES ← EN
Argus ajusta el precio objetivo de Abbott Laboratories de $140 a $125 y mantiene la calificación de compra

Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating

21/04/2026 ABT_US — Investing.com ES ← EN
Leerink recorta el precio objetivo de las acciones de Abbott Labs debido a resultados mixtos

Leerink cuts Abbott Labs stock price target on mixed results

21/04/2026 ABT_US — Quiver Quantitative
Lobbying Update: $1,410,000 of ABBOTT LABORATORIES lobbying was just disclosed
21/04/2026 ABT_US — Seeking Alpha
Abbott Laboratories Just Got Interesting: Dividend Yield Near 3% Signals Opportunity
21/04/2026 ABT_US — Seeking Alpha
Abbott Laboratories: Buy The Dip On This Dividend King (NYSE:ABT)
21/04/2026 ABT_US — Zacks
Is the Options Market Predicting a Spike in Abbott Laboratories Stock?

Página 8 de 14

keyboard_arrow_up